Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03800914




Registration number
NCT03800914
Ethics application status
Date submitted
9/01/2019
Date registered
11/01/2019
Date last updated
21/11/2024

Titles & IDs
Public title
High Intensity Interval Training in Fibrotic Interstitial Lung Disease
Scientific title
High Intensity Interval Training in Fibrotic Interstitial Lung Disease: a Randomized Controlled Trial
Secondary ID [1] 0 0
LTU HIIT in ILD
Universal Trial Number (UTN)
Trial acronym
HIIT in fILD
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Fibrotic Interstitial Lung Disease 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - High intensity interval training
Other interventions - Traditional pulmonary rehabilitation

Experimental: High Intensity Interval Training - Participants will undergo a twice-weekly supervised exercise training program for eight weeks. Each session will involve 36 minutes of interval aerobic exercise on a cycle ergometer alternating every 30 seconds between 100% of peak work rate, achieved on the cardiopulmonary exercise test (CPET), plus upper and lower resistance training.

Active comparator: Traditional pulmonary rehabilitation - Participants will undergo a twice-weekly supervised exercise training program for eight weeks. Each session will involve 30 minutes of continuous aerobic exercise on a cycle ergometer at 60% of the peak work rate achieved on the CPET, plus upper and lower resistance training.


Other interventions: High intensity interval training
36 minutes of interval exercise on cycle ergometer alternating every 30 seconds between 100% peak work rate achieved on cardiopulmonary exercise test and unloaded cycling

Other interventions: Traditional pulmonary rehabilitation
30 minutes of continuous exercise on cycle ergometer at 60% peak work rate achieved on cardiopulmonary exercise test.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Change in endurance time
Timepoint [1] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [1] 0 0
Change in dyspnea measured using the Dyspnea-12 questionnaire
Timepoint [1] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [2] 0 0
Changes in fatigue evaluated by the Fatigue Severity Scale
Timepoint [2] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [3] 0 0
Change in health related quality of life using the St George's Respiratory Questionnaire idiopathic pulmonary fibrosis specific version (SGRQ-I)
Timepoint [3] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [4] 0 0
Change in health related quality of life using the chronic respiratory disease questionnaire (CRQ)
Timepoint [4] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [5] 0 0
Change in anxiety and depression measured by the Hospital Anxiety and Depression Scale
Timepoint [5] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [6] 0 0
Change in functional exercise capacity assessed by 6-minute walk distance
Timepoint [6] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [7] 0 0
Changes in skeletal muscle size
Timepoint [7] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [8] 0 0
Dyspnea related disability - measured with modified medical research council scale (MMRC)
Timepoint [8] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [9] 0 0
Global rating of change
Timepoint [9] 0 0
Baseline, nine weeks and 6 months following intervention
Secondary outcome [10] 0 0
Change in physical activity
Timepoint [10] 0 0
Baseline, nine weeks and 6 months following intervention

Eligibility
Key inclusion criteria
* Diagnosis of fibrotic interstitial lung disease (fILD)
* Able to read and speak English
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Resting oxygen saturation (SpO2) is < 85%
* Severe pulmonary hypertension (WHO class IV)
* Attendance at Pulmonary rehabilitation (PR) within last 12 months
* Comorbidities which preclude exercise training
* History of syncope on exertion
* Significant cognitive impairment
* Anticipated transplant or death within the duration of the study period

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
17/07/2019
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/12/2024
Actual
Sample size
Target
Accrual to date
Final
131
Recruitment in Australia
Recruitment state(s)
NSW,QLD,VIC
Recruitment hospital [1] 0 0
Royal Prince Alfred Hospital - Sydney
Recruitment hospital [2] 0 0
Prince Charles Hospital - Brisbane
Recruitment hospital [3] 0 0
Austin Health - Heidelberg
Recruitment hospital [4] 0 0
Alfred Health - Melbourne
Recruitment postcode(s) [1] 0 0
2050 - Sydney
Recruitment postcode(s) [2] 0 0
4032 - Brisbane
Recruitment postcode(s) [3] 0 0
3084 - Heidelberg
Recruitment postcode(s) [4] 0 0
3004 - Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
Monash University
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Anne Holland
Address 0 0
Monash University
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Anne Holland
Address 0 0
Country 0 0
Phone 0 0
+61 3 99030214
Fax 0 0
Email 0 0
anne.holland@monash.edu
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT03800914